))
Over 60 years ago, engineer Miles Lowell Edwards and surgeon Dr. Albert Starr launched a company and an industry by developing the first commercially available artificial heart valve. Today, Edwards Lifesciences is focusing its attention on developing life-saving and groundbreaking devices that can help patients with heart valve disease. In this podcast series, we'll talk with the Edwards Lifesciences leaders who are adding to this great MedTech story. This podcast is powered by DeviceTalks ...
…
continue reading
1
Edwards’ Joe Nuzzolese on planning for disruption, prioritizing patients & automating supply chains
35:14
35:14
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
35:14
In this episode of Structural Heart Talks, Joe Nuzzolese, corporate VP of global supply chain and quality at Edwards Lifesciences, shares how the company has built a resilient and responsive supply chain capable of withstanding significant disruptions—pandemic included—without missing a single patient case. Nuzzolese explains how Edwards takes a "p…
…
continue reading
1
Todd Brinton shares lessons on mentorship, Edwards’ culture and advancing heart failure innovation
40:46
40:46
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
40:46
In this episode of Structural Heart Talks, Todd Brinton, MD, Chief Scientific Officer & CVP, Advanced Technology at Edwards Lifesciences, discusses Edwards’ vision of future innovative technologies that elevate patient care and expand the possibilities of structural heart therapies. Brinton reflects on his journey from biomedical engineering to pio…
…
continue reading
1
Edwards’ Larry Wood discusses TAVR evolution, new clinical paradigms, and addressing treatment gaps
37:15
37:15
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
37:15
In this episode of Structural Heart Talks, Larry Wood, Corporate VP and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart at Edwards Lifesciences, discusses the transformative journey of transcatheter aortic valve replacement (TAVR) and the SAPIEN valve. Wood reflects on the innovation that enables minimally inva…
…
continue reading
1
Edwards surgical structural heart SVP Markowitz highlights culture, innovation, and making an impact
22:23
22:23
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
22:23
In this episode of Structural Heart Talks, Wayne Markowitz, General Manager and SVP, Surgical Structural Heart at Edwards Lifesciences, discussed the evolving landscape of the structural heart space, emphasizing the sharpened focus at Edwards under new leadership. Markowitz highlights the importance of the surgical structural heart business, with a…
…
continue reading
1
Daveen Chopra discusses Edwards’ mitral and tricuspid focus, PASCAL and EVOQUE, and patient impacts
37:21
37:21
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
37:21
In the inaugural episode of our newest podcast, Structural Heart Talks, we sit down with Daveen Chopra, Corporate VP and GM of Transcatheter Mitral and Tricuspid Therapies (TMTT) at Edwards Lifesciences. In the episode, Chopra discusses the unique challenges of advancing therapies for the mitral and tricuspid valves, which have historically been mo…
…
continue reading
1
What to expect on the Structural Heart Talks: Edwards Lifesciences podcast
0:55
0:55
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
0:55
Nearly 70 years ago, engineer Miles Lowell Edwards and surgeon Dr. Albert Starr launched a company and an industry by developing the first commercially available artificial heart valve. Today, Edwards Lifesciences is focusing its attention on developing life-saving and groundbreaking devices that can help patients with heart disease. Hosted by Tom …
…
continue reading
